Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

8 Best US Stocks Under $10 to Invest in

Page 1 of 7

In this article, we will take a look at some of the best US stocks under $10 to invest in.

Everyone seeks a stock that has good upside potential, but a stock that is cheap and has good prospects – that’s what a steal deal looks like. From leading investors to top analysts, the financial experts have stressed one thing: a cheap price doesn’t always imply the stock’s value.

In recent times, investors have shifted their focus from high-flying tech stocks to more valuable, mispriced companies, aiming to invest in genuine bargains. As Warren Buffett says,

“Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

For instance, a study by Josef Lakonishok, Andrei Shleifer, and Robert Vishny in 1994 highlights that value stocks tend to outperform glamour stocks by substantial margins. Thus, a smart investor is the one who acquires stocks when nobody wants them.

Our Methodology

In compiling a list of the 8 best US stocks under $10 to invest in, we have selected stocks that are favorites among investors. These stocks have positive upside potential and are recommended by research firms. The upside potential is calculated using the one-year price targets by Yahoo Finance and then ranked in ascending order.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

8. Definitive Healthcare Corp. (NASDAQ:DH)

Upside potential as of August 16, 2025: 17.31%

BofA Securities has reaffirmed its Buy rating on Definitive Healthcare Corp. (NASDAQ:DH), while maintaining a price target of $4.50, implying a surge of 16.3%. This move comes as the company reports revenue and EBITDA above the research firm’s estimates and consensus forecasts.

In its latest earnings call, Definitive Healthcare Corp. (NASDAQ:DH) has raised full-year revenue guidance to $237-$240 million owing to better retention. This signals the company’s focus on streamlining its sales force. The management also announced the addition of 12 new enterprise clients within the quarter.

The company’s future looks promising, with analysts emphasizing retention rates, renewal trends, and the impact of operational changes. With strong initiatives in mind, Definitive Healthcare Corp. (NASDAQ:DH) is poised for growth.

Definitive Healthcare Corp. (NASDAQ:DH), headquartered in Massachusetts, is a provider of a SaaS healthcare commercial intelligence platform. Founded in 2011, the company has a well-diversified clientele in the biopharmaceutical, healthcare, and technology industries.

7. Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)

Upside potential as of August 16, 2025: 22.58%

Cantor Fitzgerald analysts have increased the price target on Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) to $9, up from $7, with an unchanged Overweight rating. This move follows the company’s strong quarterly performance, delivering a 29% year-over-year revenue growth.

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) appears to be in a strong position under new management, outperforming its competitors and transitioning smoothly to a small-cap company with an equally promising future. Having said that, the stock has posted a return of 115% compared to the 16.35% one-year return of the S&P 500 (^GSPC).

The company’s commitment to building a durable and high-growth business with predictable results is what sets it apart from the others. Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) also announced upward guidance during its latest earnings call. With such optimism surrounding the company, there’s no doubt that the investors are gravitating towards the stock.

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), founded in 2013, is a Massachusetts-based provider of AI weapons detection that aids in artificial intelligence (AI)-based weapons detection. The core offerings of the company include Evolv Express, Evolv Insights Analytics Application, and Evolv eXpedite.

Page 1 of 7

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.